202 related articles for article (PubMed ID: 7203370)
1. Prevalence of liver disease in patients taking salicylates for arthropathy.
Carneskog J; Florath-Ahlmen M; Olsson R
Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlations in alcoholic patients without manifest cirrhosis.
Bordalo O; Batista A; Geraldes J; Neto F; Mascarenhas F; Leitao N; Noronha M; Lamy J; Silva PE
Am J Gastroenterol; 1974 May; 61(5):371-8. PubMed ID: 4835934
[No Abstract] [Full Text] [Related]
3. [Salicylates and liver involvement. Increased aminotransferases in patients with active rheumatoid arthritis under treatment with salicylates].
Jespersen J; Ejstrup L
Ugeskr Laeger; 1979 Jul; 141(31):2119-21. PubMed ID: 483410
[No Abstract] [Full Text] [Related]
4. Biochemical evaluation of liver and pancreas following selective and subselective angiography.
Goldstein HM; Bookstein JJ
Radiology; 1974 May; 111(2):293-5. PubMed ID: 4818966
[No Abstract] [Full Text] [Related]
5. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.
Reynolds TB; Peters RL; Yamada S
N Engl J Med; 1971 Oct; 285(15):813-20. PubMed ID: 4108110
[No Abstract] [Full Text] [Related]
6. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.
Rich RR; Johnson JS
Arthritis Rheum; 1973; 16(1):1-9. PubMed ID: 4692157
[No Abstract] [Full Text] [Related]
7. [Mild forms of acute alcoholic liver damage: significance and differential diagnosis].
Linhart P; Kommerell B; Vereschild N
Dtsch Med Wochenschr; 1973 May; 98(19):983-8. PubMed ID: 4701111
[No Abstract] [Full Text] [Related]
8. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study.
Athreya BH; Moser G; Cecil HS; Myers AR
Arthritis Rheum; 1975; 18(4):347-52. PubMed ID: 1156454
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced liver disorders].
Bismuth M
Gastroenterol Clin Biol; 1999; 23(8-9):915-6. PubMed ID: 10533144
[No Abstract] [Full Text] [Related]
10. Hepatotoxicity due to treatment with papaverine. Report of four cases.
Ronnov-Jessen V; Tjernlund A
N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
[No Abstract] [Full Text] [Related]
11. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.
Seaman WE; Ishak KG; Plotz PH
Ann Intern Med; 1974 Jan; 80(1):1-8. PubMed ID: 4810348
[No Abstract] [Full Text] [Related]
12. Papaverine--hepatotoxic or not?
Driemen PM
J Am Geriatr Soc; 1973 May; 21(5):202-5. PubMed ID: 4708835
[No Abstract] [Full Text] [Related]
13. Toxic liver damage due to ethionamide.
Kuntz E; Liehr H; Pfingst W
Ger Med Mon; 1968 Dec; 13(12):599-602. PubMed ID: 5735341
[No Abstract] [Full Text] [Related]
14. [Drug-induced liver disorders. Questions for Professor Daniel Dhumeaux].
Gastroenterol Clin Biol; 1999; 23(8-9):917-20. PubMed ID: 10533145
[No Abstract] [Full Text] [Related]
15. Hepatotoxicity of papaverine.
Kiaer HW; Olsen S; Ronnov-Jessen V
Arch Pathol; 1974 Nov; 98(5):292-6. PubMed ID: 4413667
[No Abstract] [Full Text] [Related]
16. Salicylate hepatitis.
O'Gorman T; Koff RS
Gastroenterology; 1977 Apr; 72(4 Pt 1):726-8. PubMed ID: 838229
[TBL] [Abstract][Full Text] [Related]
17. Liver toxicity of a new anabolic agent: methyltrienolone (17-alpha-methyl-4,9,11-estratriene-17 beta-ol-3-one).
Krüskemper HL; Noell G
Steroids; 1966 Jul; 8(1):13-24. PubMed ID: 5955468
[No Abstract] [Full Text] [Related]
18. Liver injury by salicylates.
Br Med J; 1973 Jun; 2(5869):732. PubMed ID: 4515688
[No Abstract] [Full Text] [Related]
19. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Austerhoff A; Kindler U; Knop P; Knieriem HJ
Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
[No Abstract] [Full Text] [Related]
20. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy.
Helman RA; Temko MH; Nye SW; Fallon HJ
Ann Intern Med; 1971 Mar; 74(3):311-21. PubMed ID: 4928161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
